Filing Flows › Puma Biotechnology (PBYI) › Guidance history
Puma Biotechnology (PBYI) guidance history: what it guided and what it reported
Puma Biotechnology gave guidance in 3 earnings releases on file since May 7, 2026. Its releases raised guidance 3 times and lowered it 0 times.
Net income
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $10.0M–$12.0M (Nov 5, 2026) | — | to be reported | — |
The latest quarter
Puma Biotechnology, Q3 2026: revenue $55.1M (+1% year over year), operating margin 9.6%, net earnings $6.0M. The chart follows the revenue to costs, profit and cash.
Questions
Does Puma Biotechnology beat its guidance?
Puma Biotechnology gave guidance in 3 earnings releases on file since May 7, 2026. Its releases raised guidance 3 times and lowered it 0 times.
How often does Puma Biotechnology raise guidance?
Its earnings releases raised guidance 3 times and lowered it 0 times since May 7, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.